கார்லோஸ் கார்வால்ஹோ News Today : Breaking News, Live Updates & Top Stories | Vimarsana

 E-Mail IMAGE: Molecular neurochemist Darrell Mousseau is a professor in USask s Department of Psychiatry and head of the Cell Signalling Laboratory. view more  Credit: University of Saskatchewan Findings from a new study on Alzheimer s disease (AD), led by researchers at the University of Saskatchewan (USask), could eventually help clinicians identify people at highest risk for developing the irreversible, progressive brain disorder and pave the way for treatments that slow or prevent its onset. The research, published in the journal Scientific Reports in early January, has demonstrated that a shorter form of the protein peptide believed responsible for causing AD (beta-amyloid 42, or Aβ42) halts the damage-causing mechanism of its longer counterpart.

Carlos carvalhoJoseph buttigiegJason maleyDarrell mousseauScot learyMaa quarteyJennifer nyarkoCell signalling laboratoryUniversity of saskatchewan usaskAlzheimer society of saskatchewanMatt parsons at memorial university of newfoundlandDepartment of biochemistrySaskatchewan health research foundationSaskatchewan structural sciences centreDepartment of biologyUsask department of psychiatry